| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Growth & Innovation | President, Cardio & Vascular | SVP, Strategy and Business Dev
1 company
Andrew Senn is President, Growth & Innovation at ITGR. Andrew Senn's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $684K at current prices.
The ITGR filings lean toward selling, a net 14,408 shares.
Andrew Senn has 10 Form 4 filings on record from December 2022 to September 2026, all as President, Growth & Innovation at Integer (ITGR), 2022–2026.
The 37 reported transactions were 12 option exercises, 11 tax withholdings, 6 stock awards and 5 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $1.8M.
The largest open-market sale was 9,408 shares of ITGR at an average $126.30 on September 8, 2026, about $1.2M.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.